Two well-known names that do genuinely different things. Here is which one fits how you actually invest.
The short version. These are not really competitors. Finviz is a screener that finds candidates; TradingView is a charting platform that studies price. Both have unusually strong free tiers, and most people comparing them end up using both.
Finviz turns thousands of stocks into a shortlist in seconds and shows the clearest market heat map available. TradingView is where you study price behaviour, with the deepest charting at retail prices.
Both are unusually generous. Finviz's free screener outperforms several paid products; TradingView's free charting is enough for most individual investors.
Finviz carries basic fundamentals suitable for screening. TradingView displays them but they are clearly secondary. Neither substitutes for a financial data platform.
TradingView has a large community publishing ideas and scripts, a genuine asset that is also almost entirely unvetted. Finviz has no meaningful community layer.
Choose Finviz if you want to find candidates fast and see the market at a glance, and analyse elsewhere.
Choose TradingView if you trade on price action and want the best charting available without institutional rates.
Most people comparing Finviz and TradingView are really asking a question neither answers: how do I know whether this company is worth owning?
The problem they share. Neither answers whether the business behind the ticker is worth owning. One finds tickers, the other charts them, and the decision to own sits outside both. That gap shows up at exactly the wrong moment. When a holding falls 30%, you cannot tell a broken business from a temporary drawdown, because you never built the model the thesis rested on.
Finviz is the best free screener available and it stops exactly where the hard part begins. It narrows 8,000 stocks to 20 in seconds and offers nothing to help you work out which of those 20 is a good business.
Stock Simplifier picks up at that handover. Take a shortlist from any screener and it walks you through the business, the moat, management, growth and valuation for each name.
The two are complements rather than substitutes. Screening finds candidates; analysis decides between them, and most workflows stall precisely at that gap.
TradingView is built around price. Charts describe what a stock has done and, if you believe in technicals, what it might do next. Neither question is about whether the company behind it is worth owning.
Stock Simplifier answers the other half: the business model, the durability of the advantage, the quality of management and what the thing is actually worth.
Most long-term investors who use both keep TradingView for entries and use a research tool for the decision to own at all.
A guided wizard walks you through seven steps for any stock: the business model, its lifecycle phase, the moat, management, growth, risk and valuation. Real data from Fiscal.ai populates each step, the framework adapts to the type of company, and each concept is explained where it appears. You review, score and decide.
Where it falls short. It will not hand you a stock pick. It covers US-listed stocks only. There is no community, no earnings call transcripts and no portfolio tracker. If any of those is why you subscribe today, keep what you have and add this alongside it.
| Product | Price | Best for |
|---|---|---|
| Finviz | Free, with a paid Elite tier | Fast screening and market heat maps |
| TradingView | Free, with paid tiers | Charting and technical analysis |
| Stock Simplifier | Free plan, no card. Paid from $19.99/mo or $199/yr | Investors who want to research stocks like a pro with the help of AI so they can build their own conviction |
Instead of choosing whose conclusion to trust, reach your own. A guided wizard walks you through the business, its phase, its moat and its valuation on live data.
Free forever. No credit card · Upgrade anytime.